Akebia Therapeutics focuses on treatments for ischemia and vascular diseases.
Business Model:
Revenue: $297M
Employees: 201-500
Address: 245 First Street
City: Cambridge
State: MA
Zip: 02142
Country: US
Akebia Therapeutics focuses on treatments for ischemia and vascular diseases.
Contact Phone:
+16178712098
Contact Email:
Listed Exchange:
NASDAQ
Ticker Symbol:
AKBA
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2012 | Series B | $4.1M |
Novartis Bioventures Venture Investors Triathlon Medical Venture Partners Kearny Venture Partners Athenian Venture Partners AgeChem Venture Fund |
4/2011 | Series B | $22M |
Novartis Venture Funds Venture Investors Triathlon Medical Ventures Kearny Venture Partners Athenian Venture Partners AgeChem Venture Fund |
3/2014 | IPO | $100M |
|
9/2009 | Series A | $16M |
Novartis Venture Funds Technology Venture Investors Triathlon Medical Ventures Athenian Venture Partners Sigvion Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|